Results
Indoco Remedies Q4 FY26 Revenue Up 19% YoY
Indoco Remedies reported consolidated Q4 FY26 revenue growth of 18.8% YoY to ₹4,559 million, driven by a 94.6% surge in international formulations.
Standalone EBITDA margin improved significantly to 1
